Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Jun 5:4:5110.
doi: 10.1038/srep05110.

Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study

Affiliations
Comparative Study

Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study

Tsan-Hon Liou et al. Sci Rep. .

Abstract

The aim of this study was to investigate rheumatoid arthritis (RA), and systemic lupus erythematous (SLE) as risk factors for stroke. The study was analyzed by Using the Taiwan Longitudinal Health Insurance Database 2005 (LHID2005), this cohort study investigated patients with a recorded diagnosis of RA (N = 6114), and SLE (N = 621) between January 1, 2004, and December 31, 2007, with age-matched controls (1:4) (for RA, N = 24456; SLE, N = 2484). We used Cox proportional-hazard regressions to evaluate the hazard ratios (HRs) after adjusting confounding factors. Our study found 383 of 6114 RA patients, experienced stroke during the 20267 person-year follow-up period. The adjusted HR of stroke for RA patients was 1.24 (95% CI, 1.11 to 1.39), and for SLE patients was 1.88 (95% CI, 1.08 to 3.27). When steroid was added as additional confounding factor, the adjusted HR of ischemic stroke for RA patients was 1.32 (95% CI, 1.15 to 1.50), and for SLE patients was 1.31 (95% CI, 0.51 to 3.34). In conclusion, the rheumatic diseases of RA, and SLE are all risk factors for stroke. After controlled the effect of steroid prescription, RA is risk factor for ischemic stroke.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Plot of stroke hazard curves based on the Cox model analysis for patients with RA and SLE and comparison cohort after adjustment for age, sex, diabetes mellitus, hypertension, coronary heart diseases, hyperlipidemia, congestive heart failure, hypercoagulability, renal disease, atrial fibrillation, valvular heart disease, Aspirin use, Hydroxychloroquine use and NSAIDs use.
Figure 2
Figure 2. Plot of ischemic stroke hazard curves based on the Cox model analysis for patients with RA and SLE with or without steroid usage and comparison cohort after adjustment for age, sex, diabetes mellitus, hypertension, coronary heart diseases, hyperlipidemia, congestive heart failure, hypercoagulability, renal disease, atrial fibrillation, valvular heart disease, Aspirin use, Hydroxychloroquine use and NSAIDs use.

References

    1. Ra G. S., Yoo J. C., Kang C. J. & Kim Y. S. Microfabricated in-channel structured polydimethylsiloxane microfluidic system for a lab-on-a-chip. J Nanosci Nanotechnol 8, 4588–4592 (2008). - PubMed
    1. Donnan G. A., Fisher M., Macleod M. & Davis S. M. Stroke. Lancet 371, 1612–1623, 10.1016/S0140-6736(08)60694-7 (2008). - PubMed
    1. Jakovljevic D. et al. Socioeconomic status and ischemic stroke: The FINMONICA Stroke Register. Stroke 32, 1492–1498 (2001). - PubMed
    1. Lin H. C., Lin Y. J., Liu T. C., Chen C. S. & Chiu W. T. Urbanization and stroke prevalence in Taiwan: analysis of a nationwide survey. J Urban Health 84, 604–614, 10.1007/s11524-007-9195-1 (2007). - PMC - PubMed
    1. Chen P. C., Tseng T. C., Hsieh J. Y. & Lin H. W. Association between stroke and patients with pelvic inflammatory disease: a nationwide population-based study in taiwan. Stroke 42, 2074–2076, STROKEAHA.110.612655 [pii] 10.1161/STROKEAHA.110.612655 (2011). - PubMed

Publication types